Evolution AB (publ)
OTC:EVGGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evolution AB (publ)
OTC:EVGGF
|
SE |
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
C
|
Coles Group Ltd
SWB:2OF
|
AU |
|
J
|
JCDecaux SE
DUS:DCS
|
FR |
Wall St Price Targets
EVGGF Price Targets Summary
Evolution AB (publ)
According to Wall Street analysts, the average 1-year price target for EVGGF is 70.42 USD with a low forecast of 52.52 USD and a high forecast of 119.43 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVGGF's stock price target?
Price Target
70.42
USD
According to Wall Street analysts, the average 1-year price target for EVGGF is 70.42 USD with a low forecast of 52.52 USD and a high forecast of 119.43 USD.
What is the Revenue forecast for Evolution AB (publ)?
Projected CAGR
5%
Over the last 12 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Evolution AB (publ)?
Projected CAGR
4%
Over the last 12 years, the compound annual growth rate for Operating Income has been 51%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for Evolution AB (publ)?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Net Income has been 52%. The projected CAGR for the next 3 years is 8%.
